Powerless. Anxious. Defeated.

That’s how the parents or caregivers of a child with a peanut allergy felt every day. But there was a treatment that could help. They just didn’t know about it yet. So we had to help raise awareness of the first and only FDA-approved peanut allergy treatment, Aimmune Therapeutics’ PALFORZIA.

title content separator

Taking the power back from peanuts

Families assemble! It’s time to take on peanut allergy, put anxiety aside, and live your best lives. How? Power up with PALFORZIA. With a targeted DTC campaign, and a media strategy powered by OMD, we helped caregivers and their children take the power back from peanuts.

title content separator

The results were powerful, too

The campaign increased PALFORZIA website traffic by approx. 154% per month, user engagement by 73%, and returning traffic by 1,006%. The power of the campaign in building awareness is clear to see, but the most valuable result was the renewed assurance PALFORZIA gave to anxious children, parents, and caregivers.

title content separator

View the Video

Related case studies